Literature DB >> 33302120

Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.

Liangjie Jin1, Song Shen2, Youju Huang3, Dongdong Li4, Xianzhu Yang5.   

Abstract

Immune checkpoint blocking (ICB) antibodies have shown great success in the clinic, but their low response rate in patients with immunosuppressive cold tumors remains a huge challenge. Inspired by the capability of immunogenic cell death (ICD) to convert tumors from cold to hot, we developed a corn-like Au/Ag nanorod (NR) that can induce the ICD of tumor cells under 1064-nm light irradiation. The corn-like Au/Ag NRs plus NIR-II light irradiation strikingly increased the tumor infiltration of T cells and provoked a systemic immune response to reprogram the immunosuppressive cold tumor microenvironment; these NRs synergized with ICB antibodies to efficiently inhibit distant tumor growth. Encouragingly, the combination of aCTLA4 and Au/Ag NRs plus 1064-nm light irradiation elicited a strong immunological memory effect that protected against tumor recurrence.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Checkpoint blockade therapy; Corn-like Au/Ag nanorods; Immunogenic cell death; NIR-II PTT/PDT; Turning cold tumor microenvironment

Year:  2020        PMID: 33302120     DOI: 10.1016/j.biomaterials.2020.120582

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

Review 1.  Implications of photodynamic cancer therapy: an overview of PDT mechanisms basically and practically.

Authors:  Nafiseh Sobhani; Ali Akbar Samadani
Journal:  J Egypt Natl Canc Inst       Date:  2021-11-15

Review 2.  Recent advances in sonodynamic immunotherapy.

Authors:  Hui Wang; Guo-Qing Sui; Zhi-Xia Sun; Jia-Rui Du; Yang Wang; Zong-Hua Yue; Han-Yu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-13       Impact factor: 4.322

Review 3.  How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?

Authors:  Min Zhang; Yifan Zhao; He Ma; Yusong Sun; Jie Cao
Journal:  Theranostics       Date:  2022-05-29       Impact factor: 11.600

Review 4.  Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.

Authors:  Bin Ji; Minjie Wei; Bin Yang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 5.  Progress of Nanomaterials in Photodynamic Therapy Against Tumor.

Authors:  Lei Chen; Jiahui Huang; Xiaotong Li; Miaoting Huang; Shaoting Zeng; Jiayi Zheng; Shuyi Peng; Shiying Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

Review 6.  Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy.

Authors:  Fengshuo Wang; Jingyi Zhu; Yongtao Wang; Jingchao Li
Journal:  Nanomaterials (Basel)       Date:  2022-05-12       Impact factor: 5.719

7.  Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.

Authors:  Guoyun Wan; Xuheng Chen; Haijiao Wang; Shenglei Hou; Qian Wang; Yuanyuan Cheng; Qian Chen; Yingge Lv; Hongli Chen; Qiqing Zhang
Journal:  J Nanobiotechnology       Date:  2021-10-29       Impact factor: 10.435

8.  Dye-loaded mesoporous polydopamine nanoparticles for multimodal tumor theranostics with enhanced immunogenic cell death.

Authors:  Ying Tian; Muhammad Rizwan Younis; Yuxia Tang; Xiang Liao; Gang He; Shouju Wang; Zhaogang Teng; Peng Huang; Longjiang Zhang; Guangming Lu
Journal:  J Nanobiotechnology       Date:  2021-11-17       Impact factor: 10.435

Review 9.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

Review 10.  Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.

Authors:  Jin Zhang; Yandai Lin; Zhe Lin; Qi Wei; Jiaqi Qian; Renjie Ruan; Xiancai Jiang; Linxi Hou; Jibin Song; Jianxun Ding; Huanghao Yang
Journal:  Adv Sci (Weinh)       Date:  2021-12-19       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.